LIBMELDY 2-10 X 10^6 CELULAS/ML DISPERSION PARA PERFUSION

Orchard Therapeutics (Netherlands) B.V.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 2218d77860725072
Drug Cima Aemps Name: LIBMELDY 2-10 X 10^6 CELULAS/ML DISPERSION PARA PERFUSION
Register Number: 1201493001
Holder Company Name: Orchard Therapeutics (Netherlands) B.V.
Marketing Company Name: Orchard Therapeutics (Netherlands) B.V.
Holder Company Detail Path: /organization/orchard-therapeutics-netherlands-b-v
Marketing Company Detail Path: /organization/orchard-therapeutics-netherlands-b-v
Authorization Date: 2021-10-19
Dosage Form: DISPERSION PARA PERFUSION
Dose: 2-10 million cells/ml
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Orchard Therapeutics (Netherlands) B.V.
Company Detail Path: /organization/orchard-therapeutics-netherlands-b-v

ATIDARSAGEN AUTOTEMCEL

2-10 million células/ml

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Oct 19, 2021

Approval ID

2218d77860725072

Type

Standard